SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-22-001749
Filing Date
2022-08-12
Accepted
2022-08-12 14:18:17
Documents
55
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bdpt_10q.htm   iXBRL 10-Q 669014
2 CERTIFICATION bdpt_ex311.htm EX-31.1 9705
3 CERTIFICATION bdpt_ex312.htm EX-31.2 11443
4 CERTIFICATION bdpt_ex321.htm EX-32.1 4139
5 CERTIFICATION bdpt_ex322.htm EX-32.2 3571
11 bdpt_10qimg2.jpg GRAPHIC 4142
  Complete submission text file 0001640334-22-001749.txt   3269854

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20220630.xsd EX-101.SCH 34316
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20220630_lab.xml EX-101.LAB 203229
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20220630_cal.xml EX-101.CAL 36006
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20220630_pre.xml EX-101.PRE 173412
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20220630_def.xml EX-101.DEF 105514
49 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_10q_htm.xml XML 444219
Mailing Address 1015 S CIMARRON RD LAS VEGAS NV 89145
Business Address 1015 S CIMARRON RD LAS VEGAS NV 89145 (702) 560-1632
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

IRS No.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54949 | Film No.: 221159381
SIC: 2834 Pharmaceutical Preparations